Guardion Health Sciences, Inc. financial data

Location
2925 Richmond Avenue, Suite 1200, Houston, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.02K % +50.5%
Quick Ratio 96.4 % -10.2%
Debt-to-equity 53 % -14%
Return On Equity 77.2 %
Return On Assets 50.5 %
Operating Margin -36.4 % +80.3%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.28M shares +0.85%
Common Stock, Shares, Outstanding 1.28M shares +1.33%
Entity Public Float 9.9M USD +7.61%
Common Stock, Value, Issued 1.28K USD +1.34%
Weighted Average Number of Shares Outstanding, Basic 1.28M shares +1.33%
Weighted Average Number of Shares Outstanding, Diluted 1.3M shares +2.33%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 12.1M USD +39.3%
Research and Development Expense 91.1K USD -63.5%
Selling and Marketing Expense 1.47M USD -9.3%
General and Administrative Expense 7.26M USD -1.82%
Operating Income (Loss) -4.39M USD +72.5%
Nonoperating Income (Expense) -1.29M USD -178%
Net Income (Loss) Attributable to Parent 6.37M USD
Earnings Per Share, Basic 5 USD/shares
Earnings Per Share, Diluted 5 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 14.8M USD +77.2%
Accounts Receivable, after Allowance for Credit Loss, Current 12.7K USD -99.2%
Inventory, Net 77.8K USD -96.9%
Assets, Current 15.3M USD +13.9%
Property, Plant and Equipment, Net 6.65K USD -84.5%
Intangible Assets, Net (Excluding Goodwill) 0 USD
Assets 15.3M USD +13.5%
Accounts Payable, Current 113K USD -88.5%
Accrued Liabilities, Current 797K USD +76%
Liabilities, Current 917K USD -54.1%
Liabilities 1.55M USD -75.2%
Retained Earnings (Accumulated Deficit) -88M USD +6.76%
Stockholders' Equity Attributable to Parent 13.8M USD +89.9%
Liabilities and Equity 15.3M USD +13.5%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -755K USD +59.8%
Net Cash Provided by (Used in) Financing Activities -5.25M USD -153%
Net Cash Provided by (Used in) Investing Activities -1.65K USD +100%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Shares, Issued 1.28M shares +1.33%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -755K USD +89.4%
Deferred Tax Assets, Valuation Allowance 17M USD +2.58%
Payments to Acquire Property, Plant, and Equipment 1.65K USD -31.2%
Property, Plant and Equipment, Gross 180K USD +2.15%
Deferred Tax Assets, Operating Loss Carryforwards 11.8M USD +11.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Operating Lease, Payments 3K USD
Additional Paid in Capital 102M USD +0.13%
Preferred Stock, Shares Outstanding 0 shares
Deferred Tax Assets, Net of Valuation Allowance 1.39M USD +172%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%